Header

UZH-Logo

Maintenance Infos

Browse by Creators

Navigate back| Up a level
Export as
Number of items: 9.

von Moos, R; Seifert, B; Simcock, M; Goldinger, S M; Gillessen, S; Ochsenbein, A; Michielin, O; Cathomas, R; Schläppi, M; Moch, H; Schraml, P H; Mihic-Probst, D; Mamot, C; Schönewolf, N; Dummer, R (2012). First-line temozolomide combined with bevacizumab in metastatic melanoma: a multicentre phase II trial (SAKK 50/07). Annals of Oncology, 23(2):531-536.

Cima, I; Schiess, R; Wild, P; Kaelin, M; Schüffler, P; Lange, V; Picotti, P; Ossola, R; Templeton, A; Schubert, O; Fuchs, T; Leippold, T; Wyler, S; Zehetner, J; Jochum, W; Buhmann, J M; Cerny, T; Moch, H; Gillessen, S; Aebersold, R; Krek, W (2011). Cancer genetics-guided discovery of serum biomarker signatures for diagnosis and prognosis of prostate cancer. Proceedings of the National Academy of Sciences of the United States of America (PNAS), 108(8):3342-3347.

Cathomas, R; Berthold, D; Gillessen, S; Recker, F; Stenner, F; Strebel, R T; Sulser, T; Zwahlen, D R; Schmid, H P (2011). Das Prostatakarzinom im Wandel. Grundpfeiler der Diagnostik, Behandlung und Interdisziplinarität. Swiss Medical Forum, 11(43):759-763.

Kälin, M; Cima, I; Schiess, R; Fankhauser, N; Powles, T; Wild, P; Templeton, A; Cerny, T; Aebersold, R; Krek, W; Gillessen, S (2011). Novel prognostic markers in the serum of patients with castration-resistant prostate cancer derived from quantitative analysis of the pten conditional knockout mouse proteome. European Urology, 60(6):1235-1243.

Cathomas, R; Helbling, D; Stenner, F; Rothermundt, C; Rentsch, C; Shahin, O; Seifert, H-H; Zaugg, K; Lorch, A; Mayer, F; Beyer, J; De Santis, M; Gillessen, S (2010). Interdisciplinary evidence-based recommendations for the follow-up of testicular cancer patients: a joint effort. Swiss Medical Weekly, 140(25-26):356-369.

Gillessen, S; Templeton, A; Marra, G; Kuo, Y F; Valtorta, E; Shahinian, V B (2010). Risk of colorectal cancer in men on long-term androgen deprivation therapy for prostate cancer. Journal of the National Cancer Institute, 102(23):1760-1770.

Templeton, A; Marra, G; Valtorta, E; Heinimann, K; Müller, H; Köberle, D; Gillessen, S (2009). Concordant colon tumors in monozygotic twins previously treated for prostate cancer. Familial Cancer, 8(2):167-171.

Cathomas, R; Zbinden, S; Dummer, R; Gillessen, S; Margulies, A; Torresan, E; Stenner-Liewen, F (2009). Management der unerwünschten Wirkungen unter Sunitinib. Empfehlungen für die Therapie beim metastasierten Nierenzellkarzinom. Schweizer Zeitschrift für Onkologie, (3):24-27.

von Moos, R; Strasser, F; Gillessen, S; Zaugg, K (2008). Metastatic bone pain: treatment options with an emphasis on bisphosphonates. Supportive Care in Cancer, 16(10):1105-1115.

This list was generated on Sat Nov 25 09:10:06 2017 CET.